text: Rasagiline [<< N-propargyl-1R(+)-aminoindan >>; TVP1012] is a potent irreversible [[ monoamine oxidase ]] (MAO) inhibitor with selectivity for type B of the enzyme, which is being developed for treatment of Parkinson's disease.